Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions

NCT04283019 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04283019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04283019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
August 15, 2021
Completion date
June 17, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis, drug effects